Development of delivery methods for carbohydrate-based drugs: Controlled release of biologically-active short chain fatty acid-hexosamine analogs

Glycoconjugate Journal

Volumn 27, Issue 4, 2010, Pages 445-459

  Aich, Udayanath ^d   Meledeo, M Adam ^a   Sampathkumar, Srinivasa Gopalan ^c   Fu, Jie ^b   Jones, Mark B ^a   Weier, Christopher A ^a   Chung, Sung Yun ^a   Tang, Benjamin C ^b   Yang, Ming ^a   Hanes, Justin ^b   Yarema, Kevin J ^a  

^a Johns Hopkins University   (United States)

^b Johns Hopkins University   (United States)

^c Massachusetts Institute of Technology   (United States)

^d NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

Author keywords

Carbohydrate drug delivery; Microparticles; Nanoparticles; PEG SA polymer; SCFA hexosamine analogs

Indexed keywords

2 ACETAMIDO 2 DEOXY 1,3,4,6 TETRA O BUTANOYL ALPHA,BETA MANNOPYRANOSE; 2 ACETAMIDO 3,4,6 TRI O BUTANOYL 2 DEOXY ALPHA,BETA MANNOPYRANOSE; DRUG CARRIER; HEXOSAMINE; MICROSPHERE; NANOPARTICLE; POLY(POLYETHYLENE GLYCOL CO SEBACIC ACID); POLYMER; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; COVALENT BOND; DRUG STRUCTURE; ENCAPSULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; PILOT STUDY; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

ANTINEOPLASTIC AGENTS; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DECANOIC ACIDS; DELAYED-ACTION PREPARATIONS; DICARBOXYLIC ACIDS; DRUG DELIVERY SYSTEMS; FATTY ACIDS, VOLATILE; HEXOSAMINES; NANOPARTICLES; POLYETHYLENE GLYCOLS; POLYVINYLS;

EID: 77955653580     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-010-9292-3     Document Type: Article

References (29)

1. Liu, H., Zhang, Z., Linhardt, R.J.: Lessons learned from the contamination of heparin. Nat. Prod. Rep. 26, 313-321 (2009).
2. Meutermans, W., Le, G.T., Becker, B.: Carbohydrates as scaffolds in drug discovery. ChemMedChem 1, 1164-1194 (2006).
3. Elmouelhi, N., Aich, U., Paruchuri, V.D.P., Meledeo, M.A., Campbell, C.T., Wang, J.J., Srinivas, R., Khanna, H.S., Yarema, K.J.: Hexosamine template. A platform for modulating gene expression and for sugar-based drug discovery. J. Med. Chem. 52, 2515-2530 (2009).
4. Kayser, H., Zeitler, R., Kannicht, C., Grunow, D., Nuck, R., Reutter, W.: Biosynthesis of a nonphysiological sialic acid in different rat organs, using N-propanoyl-D-hexosamines as precursors. J. Biol. Chem. 267, 16934-16938 (1992).
5. Du, J., Meledeo, M.A., Wang, Z., Khanna, H.S., Paruchuri, V.D., Yarema, K.J.: Metabolic glycoengineering: Sialic acid and beyond. Glycobiology 19, 1382-1401 (2009).
6. Sarkar, A.K., Fritz, T.A., Taylor, W.H., Esko, J.D.: Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated Gal β1, 4GlcNAc β-O-naphthalenemethanol. Proc. Natl. Acad. Sci. U.S.A. 92, 3323-3327 (1995).
7. Kim, E.J., Sampathkumar, S.-G., Jones, M.B., Rhee, J.K., Baskaran, G., Yarema, K.J.: Characterization of the metabolic flux and apoptotic effects of O-hydroxyl- and N-acetylmannosamine (ManNAc) analogs in Jurkat (human T-lymphoma-derived) cells. J. Biol. Chem. 279, 18342-18352 (2004).
8. Aich, U., Campbell, C.T., Elmouelhi, N., Weier, C.A., Sampathkumar, S.-G., Choi, S.S., Yarema, K.J.: Regioisomeric SCFA attachment to hexosamines separates metabolic flux from cytotoxcity and MUC1 suppression. ACS Chem. Biol. 3, 230-240 (2008).
9. Campbell, C.T., Aich, U., Weier, C.A., Wang, J.J., Choi, S.S., Wen, M.M., Maisel, K., Sampathkumar, S.-G., Yarema, K.J.: Targeting pro-invasive oncogenes with short chain fatty acid-hexosamine analogs inhibits the mobility of metastatic MDA-MB-231 breast cancer cell. J. Med. Chem. 51, 8135-8147 (2008).
10. Sampathkumar, S.-G., Jones, M.B., Meledeo, M.A., Campbell, C.T., Choi, S.S., Hida, K., Gomutputra, P., Sheh, A., Gilmartin, T., Head, S.R., Yarema, K.J.: Targeting glycosylation pathways and the cell cycle: sugar- dependent activity of butyrate-carbohydrate cancer prodrugs. Chem. Biol. 13, 1265-1275 (2006).
11. Wang, Z., Du, J., Che, P.-L., Meledeo, M.A., Yarema, K.J.: Hexosamine analogs: from metabolic glycoengineering to drug discovery. Curr. Opin. Chem. Biol. 13, 565-572 (2009).
12. Viswanathan, K., Lawrence, S., Hinderlich, S., Yarema, K.J., Lee, Y.C., Betenbaugh, M.: Engineering sialic acid synthetic ability into insect cells: identifying metabolic bottlenecks and devising strategies to overcome them. Biochemistry 42, 15215-15225 (2003).
13. Campbell, C.T., Sampathkumar, S.-G., Weier, C., Yarema, K.J.: Metabolic oligosaccharide engineering: perspectives, applications, and future directions. Mol. Biosyst. 3, 187-194 (2007).
14. Aich, U., Yarema, K.J.: Metabolic oligosaccharide engineering: perspectives, applications, and future directions. In: Fraser-Reid, B., Tatsuta, K., Thiem, J. (eds.) Glycosciences, 2nd edn, pp. 2136- 2190. Springer-Verlag, Berlin (2008).
15. Sarkar, A.K., Brown, J.R., Esko, J.D.: Synthesis and glycan priming activity of acetylated disaccharides. Carbohydr. Res. 329, 287-300 (2000).
16. Gagiannis, D., Gossrau, R., Reutter, W., Zimmermann-Kordmann, M., Horstkorte, R.: Engineering the sialic acid in organs of mice using N-propanoylmannosamine. Biochim. Biophys. Acta 1770, 297-306 (2007).
17. Fu, J., Fiegel, J., Krauland, E., Hanes, J.: New polymeric carriers for controlled drug delivery following inhalation or injection. Biomaterials 23, 4425-4433 (2002).
18. Zhang, I., Gu, F.X., Chan, J.M., Wang, A.Z., Langer, R.S., Farokhzad, O.C.: Nanoparticles in medicine: therapeutic applications and developments. Clin. Pharmacol. Ther. 83, 761-769 (2008).
19. Quick, D.J., Macdonald, K.K., Anseth, K.S.: Delivering DNA from photocrosslinked, surface eroding polyanhydrides. J. Control. Release 97, 333-343 (2004).
20. Jones, M.B., Teng, H., Rhee, J.K., Baskaran, G., Lahar, N., Yarema, K.J.: Characterization of the cellular uptake and metabolic conversion of acetylated N-acetylmannosamine (ManNAc) analogues to sialic acids. Biotechnol. Bioeng. 85, 394-405 (2004).
21. Tanner, M.E.: The enzymes of sialic acid biosynthesis. Bioorg. Chem. 33, 216-228 (2005).
22. Luchansky, S.J., Yarema, K.J., Takahashi, S., Bertozzi, C.R.: GlcNAc 2-epimerase can serve a catabolic role in sialic acid metabolism. J. Biol. Chem. 278, 8036-8042 (2003).
23. Sampathkumar, S.-G., Campbell, C.T., Weier, C., Yarema, K.J.: Short-chain fatty acid-hexosamine cancer prodrugs: the sugar matters! Drug. Future 31, 1099-1116 (2006).
24. Lavis, L.D.: Ester bonds in prodrugs. ACS Chem. Biol. 3, 203- 206 (2008).
25. Luchansky, S.J., Argade, S., Hayes, B.K., Bertozzi, C.R.: Metabolic functionalization of recombinant glycoproteins. Biochemistry 43, 12358-12366 (2004).
26. Whalen, M.M., Wild, G.C., Spall, W.D., Sebring, R.J.: Separation of underivatized gangliosides by ion exchange high performance liquid chromatography. Lipids 21, 267-270 (1986).
27. Kim, E.J., Jones, M.B., Rhee, J.K., Sampathkumar, S.-G., Yarema, K.J.: Establishment of N-acetylmannosamine (ManNAc) analogue-resistant cell lines as improved hosts for sialic acid engineering applications. Biotechnol. Prog. 20, 1674-1682 (2004).
28. Jourdian, G.W., Dean, L., Roseman, S.: The sialic acids. XI. A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides. J. Biol. Chem. 246, 430-435 (1971).
29. Yarema, K.J., Goon, S., Bertozzi, C.R.: Metabolic selection of glycosylation defects in human cells. Nat. Biotechnol. 19, 553- 558 (2001).